NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$22.65
-2.87%
Mkt Cap $2.47B
EPS — Estimate vs Actual
Mkt Cap
$2.47B
P/E
—
Fwd P/E
—
P/S
109.63
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$22.65
-2.87%
Mkt Cap $2.47B
Mkt Cap
$2.47B
P/E
—
Fwd P/E
—
P/S
109.63
Rev TTM
—
EPS TTM
-$1.81